COMMUNIQUÉS West-GlobeNewswire

Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15
21/05/2025
Study is expected to deliver final device data and documentation needed for planned FDA IND submission SARASOTA, FL, May 21, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a [...]
WORK Medical Technology Group LTD Announces Pricing of Registered Offering
21/05/2025
Hangzhou, China, May 21, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) [...]
Bioxytran’s Antiviral Breakthrough Featured in University of Georgia’s $100M HPAI Poultry Innovation Grand Challenge Submission
21/05/2025
PHM23 was one of a handful of molecules chosen by the university Bird Flu helping PHM23 gain awareness of broad-spectrum activity at a university level BOSTON, MASSACHUSETTS, May 21, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, [...]
Synfini Inc. and Multispan Announce Drug Discovery Collaboration
21/05/2025
Collaboration Combines Best-in-Class Biology with Agile AI and Chemistry Automation for Rapid Discovery of Better Molecules for Highly Valuable G Protein-Coupled Receptor (GPCR) Targets MENLO PARK, Calif., May 21, 2025 [...]
Aeroflow Health Expands Lactation Coverage for Mothers Across Twelve States Through Medicaid
21/05/2025
The durable medical equipment provider is continuing its mission of improving maternal health outcomes by now providing virtual lactation services to new mothers under Medicaid. ASHEVILLE, N.C. , May 21, 2025 (GLOBE [...]
Complement 1 Appoints Dr. Christopher Cogle as Chief Medical Officer to Lead Clinical Strategy for Innovative Cancer Lifestyle Platform
21/05/2025
Renowned oncologist and translational researcher to spearhead medical strategy as company scales innovative lifestyle modification model NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Complement 1 , a pioneering health [...]
NEXGEL to Participate in the 6th Annual CEO Networking Event Hosted by Semco Capital on June 2nd
21/05/2025
LANGHORNE, Pa., May 21, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content [...]
Celeste Lajala Named Instructor of the Year by National Fitness Program, SilverSneakers, For Improving Senior Fitness in Hawaii
21/05/2025
Transitioning from a career in medicine to fitness instruction, Lajala now empowers older adults to age with strength and confidence by fostering movement, connection and community NASHVILLE, Tenn., May 21, 2025 (GLOBE [...]
Alumis Completes Merger with ACELYRIN
21/05/2025
Establishes leading clinical stage biopharma company with differentiated portfolio of therapies and strong balance sheet SOUTH SAN FRANCISCO, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a late- [...]
Globally Recognized Expert in Rare Autoimmune Neurologic Diseases, Dr. Benjamin Greenberg, Joins Trethera Scientific Advisory Board
21/05/2025
LOS ANGELES, May 21, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, announced today the [...]
GRI Bio to Participate in the Virtual Investor Closing Bell Series
21/05/2025
Live webcast on Wednesday, May 28 th at 4:00 PM ET LA JOLLA, CA, May 21, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of [...]
Invivyd Commends FDA Focus on Contemporary Evidence In Evaluating Medical Interventions To Prevent COVID-19
21/05/2025
FDA acknowledges that the benefit of repeat doses of COVID-19 vaccine boosters for Americans is uncertain; the updated regulatory framework for COVID-19 vaccines articulated by the Agency generally aligns with recent [...]
SynVivo Appoints Dr. Richard Eglen to Board of Directors
21/05/2025
HUNTSVILLE, Ala., May 21, 2025 (GLOBE NEWSWIRE) -- SynVivo , a pioneering organ-on-chip company developing advanced microfluidic platforms that replicate human tissue microenvironments for drug discovery, today [...]
SPRINT® PNS Meets Primary Endpoint of Reduction in Head Pain in First Publication of Multicenter Prospective MONARCH™ Study
21/05/2025
CLEVELAND, May 21, 2025 (GLOBE NEWSWIRE) -- Today, SPR announced the publication of the MONARCH (Multicenter Occipital Neuralgia and Cervicogenic Headache) Study, which evaluates the use of 60-day SPRINT PNS treatment [...]
Spinal Rehab & Sports Medicine Celebrates Two-Year Milestone of Dr. Josh Meyer, D.C.—Extending a Legacy of Excellence in Austin, TX
21/05/2025
AUSTIN, Texas, May 21, 2025 (GLOBE NEWSWIRE) -- Spinal Rehab & Sports Medicine , a cornerstone of sports injury recovery and performance care in Austin for over 25 years, proudly celebrates the two-year anniversary [...]
Genmab to Participate in a Fireside Chat at the 2025 Jefferies Global Health Care Conference
21/05/2025
Media Release COPENHAGEN, Denmark; May 21, 2025 Genmab A/S (Nasdaq: GMAB ) a nnounced today that its Chief Development Officer Judith Klimovsky will participate in a fireside chat at the 2025 Jefferies Global Health [...]
Best Place to Order Anavar USA 2025 | $25 Off + Fast US Ship
21/05/2025
Anavar (Oxandrolone) tops many cutting-stack plans. Wonderfully, it hardens muscle, keeps strength climbing, and leaves physiques looking sharp for photo day or stage time. When the goal is a tighter outline by summer, [...]
EuroPCR 2025 : Des données récentes démontrent une réduction durable et statistiquement significative des taux d’événements avec le bioadaptateur DynamX® d’Elixir Medical par rapport au stent à élution médicamenteuse (SEM) sur trois ans
21/05/2025
Paris, 21 mai 2025 (GLOBE NEWSWIRE) -- —Un effet thérapeutique durable avec des taux de TLF significativement inférieurs (2,7 % contre 7,2 %, p = 0,030) avec DynamX ® par rapport au SEM— —Taux de décès cardiaque [...]
EuroPCR 2025: Late-Breaking Data Demonstrate Sustained Significantly Lower Event Rates With Elixir Medical’s DynamX Bioadaptor Over Drug-Eluting Stent Through Three Years
21/05/2025
Paris, May 21, 2025 (GLOBE NEWSWIRE) -- —Sustained durability of treatment effect with significantly lower TLF rates (2.7% versus 7.2%, p=0.030) with DynamX ® compared to DES— —Significantly lower rate of Cardiac Death [...]

Pages